Sierra Summit Advisors LLC Acquires 4,636 Shares of Astera Labs, Inc. $ALAB

Sierra Summit Advisors LLC grew its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 4.8% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 100,229 shares of the company’s stock after purchasing an additional 4,636 shares during the period. Astera Labs makes up approximately 1.6% of Sierra Summit Advisors LLC’s holdings, making the stock its 23rd largest position. Sierra Summit Advisors LLC’s holdings in Astera Labs were worth $10,985,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Reflection Asset Management purchased a new stake in shares of Astera Labs in the 4th quarter worth approximately $25,000. Smartleaf Asset Management LLC boosted its holdings in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares in the last quarter. Hilltop National Bank boosted its holdings in Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after acquiring an additional 100 shares in the last quarter. Aventura Private Wealth LLC purchased a new stake in shares of Astera Labs in the fourth quarter worth $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in shares of Astera Labs in the fourth quarter worth $33,000. 60.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently weighed in on ALAB shares. Evercore restated an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Needham & Company LLC lifted their target price on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Finally, UBS Group upped their target price on shares of Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a research note on Monday. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average target price of $265.75.

Astera Labs Trading Down 5.7%

Astera Labs stock opened at $406.42 on Friday. The firm has a market cap of $69.66 billion, a price-to-earnings ratio of 274.61, a PEG ratio of 4.94 and a beta of 3.66. Astera Labs, Inc. has a 12 month low of $88.18 and a 12 month high of $499.48. The stock has a fifty day simple moving average of $310.47 and a two-hundred day simple moving average of $204.14.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same period last year, the company earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other news, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the transaction, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the transaction, the director owned 57,466 shares in the company, valued at approximately $25,859,700. This trade represents a 5.75% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 1,981,441 shares of company stock valued at $444,969,514. Company insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.